相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
Wim H. J. Kruit et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer
Aimee R. Kreimer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Adjuvant MAGE-A3 Immunotherapy in Resected Non-Small-Cell Lung Cancer: Phase II Randomized Study Results
Johan Vansteenkiste et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
B7-H1 Expression Model for Immune Evasion in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
Odey C. Ukpo et al.
HEAD & NECK PATHOLOGY (2013)
Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
Dung T. Le et al.
CANCER RESEARCH (2012)
inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma
Caroline J. Voskens et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
The clinical implications of antitumor immunity in head and neck cancer
Clint T. Allen et al.
LARYNGOSCOPE (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
HIGH EXPRESSION OF CANCER TESTIS ANTIGENS MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, AND GAGE IN ADVANCED SQUAMOUS CELL CARCINOMA OF THE LARYNX
David L. A. Figueiredo et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Therapeutic cancer vaccines: are we there yet?
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2011)
Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma
Cyril Cuffel et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
ACR APPROPRIATENESS CRITERIA® RETREATMENT OF RECURRENT HEAD AND NECK CANCER AFTER PRIOR DEFINITIVE RADIATION
Mark W. McDonald et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Optimal treatment for recurrent/metastatic head and neck cancer
J. B. Vermorken et al.
ANNALS OF ONCOLOGY (2010)
Down-Regulation of HLA Class I Antigen in Human Papillomavirus Type 16 E7 Expressing HaCaT Cells Correlate With TAP-1 Expression
Wei Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
HPV-16 E5 down-regulates expression of surface HLA class I by CD8 T cells
M. S. Campo et al.
VIROLOGY (2010)
Synthetic Peptide-Based Cancer Vaccines: Lessons Learned and Hurdles to Overcome
Caroline J. Voskens et al.
CURRENT MOLECULAR MEDICINE (2009)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
Improving vaccine delivery using novel adjuvant systems
Michael E. Pichichero
HUMAN VACCINES (2008)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)
Sadamoto Zenda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Cancer/testis genes in multiple myeloma:: Expression patterns and prognosis value determined by microarray analysis
Maud Condomines et al.
JOURNAL OF IMMUNOLOGY (2007)
Therapeutic vaccination for HPV induced cervical cancers
Joeli A. Brinkman et al.
DISEASE MARKERS (2007)
Protective mechanisms of head and neck squamous cell carcinomas from immune assault
MRI Young
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma
WHJ Kruit et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
AA Jungbluth et al.
BLOOD (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review
AR Kreimer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses
J Lu et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients
D Atanackovic et al.
JOURNAL OF IMMUNOLOGY (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report
M Marchand et al.
EUROPEAN JOURNAL OF CANCER (2003)
TAP-Independent presentation of CTL epitopes by trojan antigens
J Lu et al.
JOURNAL OF IMMUNOLOGY (2001)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
